Literature DB >> 18216474

Medical history, drug exposure and the risk of psoriasis. Evidence from an Italian case-control study.

Luigi Naldi1, Liliane Chatenoud, Anna Belloni, Andrea Peserico, Nicola Balato, Anna Rosa Virgili, Pier Luigi Bruni, Vito Ingordo, Giovanni Lo Scocco, Carmen Solaroli, Donatella Schena, Anna Di Landro, Enrico Pezzarossa, Fabio Arcangeli, Claudia Gianni, Roberto Betti, Paolo Carli, Alessandro Farris, Gian Franco Barabino, Carlo La Vecchia, Fabio Parazzini.   

Abstract

BACKGROUND/AIMS: To evaluate the association of psoriasis with selected medical conditions and a number of drugs used before diagnosis.
METHODS: Multicenter case-control study involving outpatient services of 20 general and teaching hospitals. Entry criteria for cases were a first diagnosis of psoriasis made by a dermatologist and a history of skin manifestations of no more than 2 years after the reported onset of the disease. Controls were the first eligible dermatological patients observed on randomly selected days in the same centers as cases. A total of 560 cases and 690 controls were recruited.
RESULTS: The odds ratio (OR) of psoriasis was 0.8 (95% confidence interval, CI, 0.5-1.3) in hypertensive subjects, 1.1 (95% CI 0.6-2.0) in diabetics and 1.1 (95% CI 0.7-1.7) in hyperlipidemic subjects. Histamine 2 receptor antagonist exposure was negatively associated with psoriasis: OR 0.3 (95% CI 0.1-0.8).
CONCLUSION: Our study rules out a strong association of psoriasis at its first ever diagnosis with common chronic conditions. The reported associations of psoriasis with relatively common conditions such as diabetes mellitus, hypertension and hyperlipidemia may represent a late effect of well-known risk factors for psoriasis such as smoking and overweight or reflect factors related to the long course of psoriasis itself. (c) 2008 S. Karger AG, Basel.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18216474     DOI: 10.1159/000111509

Source DB:  PubMed          Journal:  Dermatology        ISSN: 1018-8665            Impact factor:   5.366


  7 in total

Review 1.  Psoriasis and vascular disease-risk factors and outcomes: a systematic review of the literature.

Authors:  Rita V Patel; Michael L Shelling; Srdjan Prodanovich; Daniel G Federman; Robert S Kirsner
Journal:  J Gen Intern Med       Date:  2011-04-07       Impact factor: 5.128

2.  Personal history of gallstones and risk of incident psoriasis and psoriatic arthritis in U.S. women.

Authors:  L X Tong; S Wu; T Li; A A Qureshi; E L Giovannucci; E Cho
Journal:  Br J Dermatol       Date:  2015-02-15       Impact factor: 9.302

3.  The role of epigenetic mechanisms and processes in autoimmune disorders.

Authors:  Judith M Greer; Pamela A McCombe
Journal:  Biologics       Date:  2012-09-06

4.  Psoriasis and risk of type 2 diabetes among women and men in the United States: a population-based cohort study.

Authors:  Wenqing Li; Jiali Han; Frank B Hu; Gary C Curhan; Abrar A Qureshi
Journal:  J Invest Dermatol       Date:  2011-10-13       Impact factor: 8.551

Review 5.  Type 2 diabetes and psoriasis: links and risks.

Authors:  Jesper Grønlund Holm; Simon Francis Thomsen
Journal:  Psoriasis (Auckl)       Date:  2019-01-17

6.  Obesity and dyslipidemia in patients with psoriasis treated at a dermatologic clinic in Manaus.

Authors:  Mônica Santos; Hannah Monteiro Fonseca; Alex Panizza Jalkh; Gabriela Piraice Gomes; Andrea de Souza Cavalcante
Journal:  An Bras Dermatol       Date:  2013 Nov-Dec       Impact factor: 1.896

7.  Impact of smoking on psoriasis risk and treatment efficacy: a meta-analysis.

Authors:  Hang Zhou; Ruifang Wu; Yi Kong; Ming Zhao; Yuwen Su
Journal:  J Int Med Res       Date:  2020-10       Impact factor: 1.671

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.